FDA OKs novel surgical clotting solution

Jan 17, 2008

The U.S. Food and Drug Administration announced approval Thursday of the first clotting solution made using recombinant DNA techniques.

The FDA said the new solution, called Recothrom, is a topical solution designed to stop small blood vessels from bleeding following surgery. Recombinant DNA is the result of a genetic modification process that enables scientists to create new DNA strands with specific traits, such as the capacity to produce a specific protein.

The FDA said post-surgical bleeding from small blood vessels, such as capillaries, can cause significant blood loss. Physicians can apply Recothrom during surgery when standard surgical techniques for stopping blood loss are ineffective or impractical.

"With today's approval, surgeons can choose recombinant thrombin, thrombin derived from human plasma or thrombin derived from cattle plasma to help control surgical bleeding and oozing," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research.

Recothrom is made from Chinese hamster ovary cells that have been genetically modified to produce human thrombin. The cells are free from known infectious agents, the FDA said, noting Recothrom undergoes an additional process of viral inactivation.

Recothrom is manufactured by ZymoGenetics Inc. of Seattle.

Copyright 2008 by United Press International

Explore further: Liver transplant recipient marks 25th anniversary

add to favorites email to friend print save as pdf

Related Stories

FDA OKs new adhesive to treat burn victims

Mar 20, 2008

The U.S. Food and Drug Administration approved a medical adhesive -- a fibrin sealant called Artiss -- for use in attaching skin grafts to burn patients.

Recommended for you

Thai parliament votes to ban commercial surrogacy (Update)

1 hour ago

Thailand's parliament has voted to ban commercial surrogacy after outrage erupted over the unregulated industry following a series scandals including the case of an Australian couple accused of abandoning a baby with Down's ...

Doctor behind 'free radical' aging theory dies

Nov 25, 2014

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.